TUMOR NECROSIS FACTOR ALPHA INHIBITORS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Ubago, R. [1 ]
Castillo, M. A. [1 ]
Marin, R. [2 ]
Flores, S. [3 ]
Rodriguez, R. [1 ]
机构：
[1] Agencia Evaluac Tecnol Sanitarias Andalucia, Seville, Andalucia, Spain
[2] Hosp Univ Virgen Rocio, Seville, Andalucia, Spain
[3] Andalusian Agcy Hlth & Technol Assessment, Seville, Andalucia, Spain
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.387
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [31] Tumor necrosis factor gene polymorphisms in ankylosing spondylitis
    Fraile, A
    Nieto, A
    Beraún, Y
    Vinasco, J
    Matarán, L
    Martín, J
    TISSUE ANTIGENS, 1998, 51 (04): : 386 - 390
  • [32] DRUG SURVIVAL OF TUMOR NECROSIS FACTOR-α INHIBITORS IN PATIENTS WITH ANKYLOSING SPONDYLITIS IN KOREA
    Jeong, H.
    Kim, H.
    Oh, J. -M.
    Kim, J.
    Lee, J.
    Koh, E. -M.
    Cha, H. -S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 804 - 804
  • [33] Predicting Probability of Response to Tumor Necrosis Factor Inhibitors for Individual Patients With Ankylosing Spondylitis
    Wang, Runsheng
    Dasgupta, Abhijit
    Ward, Michael M.
    JAMA NETWORK OPEN, 2022, 5 (03)
  • [34] Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors
    Maas, Fiona
    Arends, Suzanne
    Brouwer, Elisabeth
    Essers, Ivette
    van der Veer, Eveline
    Efde, Monique
    van Ooijen, Peter M. A.
    Wolf, Rinze
    Veeger, Nic J. G. M.
    Bootsma, Hendrika
    Wink, Freke R.
    Spoorenberg, Anneke
    ARTHRITIS CARE & RESEARCH, 2017, 69 (07) : 1011 - 1019
  • [35] THE EFFECTIVENESS OF MONOCLONAL ANTIBODIES TO TUMOR NECROSIS FACTOR ALPHA: INFLIXIMAB IN JUVENILE ANKYLOSING SPONDYLITIS
    Alexeeva, Ekaterina
    Kozlova, Anna
    Valieva, Saniya
    Bzarova, Tatyana
    Chomahizde, Alexandra
    Isaeva, Kseniya
    Denisova, Rina
    Slepcova, Tatyana
    RHEUMATOLOGY, 2012, 51 : I34 - I34
  • [36] Adverse events of tumor necrosis factor alpha inhibitors for the treatment of ankylosing spondylitis: A meta-analysis of randomized, placebo-controlled trials
    Feng, Haihuan
    Zhao, Ying
    Kuang, Weihong
    Dai, Yanping
    Cen, Xiaobo
    Qin, Feng
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [37] Improvement in Ankylosing Spondylitis Disease Activity Score in Patients with Ankylosing Spondylitis Treated with Tumor Necrosis Factor-Alpha Blocking Therapy
    Arends, Suzanne
    van der Veer, Eveline
    Houtman, Pieternella M.
    Leijsma, Martha K.
    Kallenberg, Cees G. M.
    Brouwer, Elisabeth
    Spoorenberg, Anneke
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S517 - S517
  • [38] Quality of life and productivity loss in patients with ankylosing spondylitis using tumor necrosis factor inhibitors
    Ma, Kevin Sheng-Kai
    Kao, Pei-En
    Chen, Kun-Hui
    Liu, Chin-Hsiu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (07) : 1412 - 1413
  • [39] NSAIDS MODIFY THE EFFECT OF TUMOR NECROSIS FACTOR INHIBITORS ON NEW BONE FORMATION IN ANKYLOSING SPONDYLITIS
    Gensler, L.
    Reveille, J. D.
    Ward, M. M.
    Brown, M. A.
    Rahbar, M.
    Lee, M.
    Weisman, M. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 805 - 806
  • [40] Effect of Tumor Necrosis Factor Inhibitors on Hip Involvement in Ankylosing Spondylitis: Is Structural Repair Possible?
    Slouma, Maroua
    Rouatbi, Feriel
    Ben Ammar, Lobna
    Gharsallah, Imen
    JOURNAL OF RHEUMATOLOGY, 2024, 51 (01) : 104 - 105
12345